Pfizer ١٢ مايو ٢٠٢٦ Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu - Fierce Pharma
Pfizer ١٢ مايو ٢٠٢٦ BridgeBio’s Attruby challenges Pfizer’s Vyndamax legacy in pivotal ATTR trial - Clinical Trials Arena
Pfizer ١٢ مايو ٢٠٢٦ Pfizer Ltd stock (INE182A01018): Indian pharma subsidiary eyes growth - AD HOC NEWS
Pfizer ٦ مايو ٢٠٢٦ Cytospire’s backers buy in as Pfizer exits | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Pfizer ٥ مايو ٢٠٢٦ Pfizer’s $2.3B Trillium bet ends in failure as remaining CD47 blocker scrapped along with T-cell engager - Fierce Biotech
Pfizer ٥ مايو ٢٠٢٦ FDA approves Pfizer and Arvina’s breast cancer drug despite weak clinical data - medwatch.com
Pfizer ٤ مايو ٢٠٢٦ Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era - 24/7 Wall St.
Pfizer ٤ مايو ٢٠٢٦ Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era - Yahoo Finance
Pfizer ١ مايو ٢٠٢٦ FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype - Fierce Pharma